Testing version — LOERadar is in active testing. Features and data may change.
RIVASTIGMINE (RIVASTIGMINE TARTRATE) | LOERadar
Tentative Approval — This application has been tentatively approved by the FDA but is not yet listed in the Orange Book. It is blocked from final approval by unexpired patents or exclusivities on the reference listed drug.
RIVASTIGMINE
ANDATentative Approval
RIVASTIGMINE TARTRATE | A077363 | RANBAXY
Products (1)
#001 — 2MG/ML
▴
SOLUTION; ORAL | TA Date: 2005-12-21 00:00:00
No patent or exclusivity listings for this strength.